COMMUNIQUÉS West-GlobeNewswire

BioRestorative Therapies Signs $5.4 Million Financing with Institutional Investor
31/07/2019
MELVILLE, N.Y., July 31, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it has entered into a [...]
Hepion Pharmaceuticals Announces Research Partnership with Applied Pharmaceutical Innovation, Faculty of Pharmacy & Pharmaceutical Sciences at University of Alberta
31/07/2019
- Accelerating NASH Research Programs - EDISON, N.J., July 31, 2019 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a biopharmaceutical company focused on the development of therapeutic drugs for the [...]
Generex Biotechnology Introduces Pantheon Medical, the Newest Member of the NuGenerex Family of Companies
31/07/2019
Pantheon Medical Line of Orthopedic Implants “All-in-One” Foot & Ankle Kits https://pantheonortho.com MIRAMAR, Fla., July 31, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB: [...]
Alphatec Holdings, Inc. Announces Pricing of Public Offering of Common Stock
31/07/2019
CARLSBAD, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today [...]
LifePod and Commonwealth Care Alliance Announce Expansion of LifePod’s Proactive-Voice Service to 500 More Members
31/07/2019
Positive care outcomes and cost reductions lead LifePod and CCA to extend pilot program BOSTON, July 31, 2019 (GLOBE NEWSWIRE) -- LifePod ® Solutions, the first proactive-voice, AI-powered caregiver service and [...]
TZOA Launches Canada’s First All-in-One Smart Home Air Filtration Solution, HAVEN
31/07/2019
Capable of improving residential air quality by upwards of 90 percent, HAVEN will be available for purchase across Western Canada over the next three months in time for forest fire season air quality concerns VANCOUVER [...]
Afrezza® Safety and Pharmacokinetics Study in Pediatric Patients Opens Enrollment for Cohort 3
31/07/2019
MannKind announces the opening of enrollment for this final cohort before moving to phase 3 in this pediatric clinical trial WESTLAKE VILLAGE, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD [...]
Ritter Pharmaceuticals Hosts Conference Call on August 7, 2019 to Highlight Recent Lactose Intolerance Market Research Findings
31/07/2019
Daniel P. Lundberg, Consultant to Ritter Pharmaceuticals and former Senior VP of Marketing at Salix Pharmaceuticals to address market opportunity for Phase 3, lactose intolerance drug candidate RP-G28 LOS ANGELES, July [...]
Teladoc Health Names Health Tech Veteran David Sides as Chief Operating Officer
31/07/2019
PURCHASE, NY, July 31, 2019 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, announced that it has named David Sides as chief operating officer. A former corporate CEO and a longtime [...]
Turning Point Therapeutics Initiates Phase 1 Clinical Study of Tpx-0022, a Novel Met Inhibitor Targeting Advanced Solid Tumors
31/07/2019
SAN DIEGO, July 31, 2019 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing novel drugs to address treatment resistance, today announced initiation of a Phase 1 [...]
SeaSpine Announces Launch of Mariner® Outrigger® Revision System
31/07/2019
CARLSBAD, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]
Atlas Nanotech Opens First Revenue Stream
31/07/2019
Multipurpose contract signed with Gem Labs GUADALAJARA, Mexico, July 31, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – CSSI (Costas Inc.), DBA Atlas Nanotech, today memorialized an agreement with Laboratorios Gem S.A. de C [...]
Menlo Therapeutics to Present at the 2019 Wedbush PacGrow Healthcare Conference
31/07/2019
REDWOOD CITY, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), [...]
ChemoCentryx to Hold Second Quarter 2019 Financial Results Conference Call on Monday, August 5, 2019
31/07/2019
MOUNTAIN VIEW, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's second quarter 2019 financial results will be released after market close on Monday, August [...]
Stryker declares a $0.52 per share quarterly dividend
31/07/2019
Kalamazoo, Michigan, July 31, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.52 per share payable on October 31, 2019 to shareholders of record [...]
SELLAS Advances Galinpepimut-S (GPS) in Combination with KEYTRUDA® (pembrolizumab) Program with Dosing of First Patient in Phase 1/2 Basket Study
31/07/2019
- Study is Being Conducted with Merck Under a Clinical Trial Collaboration and Supply Agreement - - Trial to Enroll Patients with Ovarian, Colorectal, Triple Negative Breast, and Small Cell Lung Cancers and Acute [...]
Helsinn and Endo Announce Agreement for Paladin Labs Inc. to Commercialize Pracinostat in Canada
31/07/2019
Helsinn and Endo Announce Agreement for Paladin Labs Inc. to Commercialize Pracinostat in Canada DUBLIN and LUGANO, July 31, 2019 -- Endo International plc (NASDAQ: ENDP), and Helsinn, a Swiss pharmaceutical group [...]
Catalyst Pharmaceuticals to Hold Second Quarter 2019 Financial Results Conference Call and Webcast on Thursday, August 8th, 2019
31/07/2019
CORAL GABLES, Fla., July 31, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]
Forty Seven Inc. to Present at Canaccord Genuity 39th Annual Growth Conference
31/07/2019
MENLO PARK, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- Forty Seven Inc. (NASDAQ:FTSV), a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today [...]

Pages